Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2025 08:00 ET | Source: Numab Therapeutics AG

Numab Therapeutics Achieves Milestone in Collaboration with Boehringer Ingelheim

Numab to receive first milestone payment Boehringer Ingelheim has advanced its novel tumor antigen targeting T cell engager resulting from a collaboration with Numab into preclinical...
August 28, 2025 12:12 ET | Source: Spherix Global Insights

Gene and Oral Therapies Drive Urgency and Innovation in Retinal Care, Reshaping Ophthalmology’s Future, According to Spherix Global Insights

Exton, Pennsylvania, Aug. 28, 2025 (GLOBE NEWSWIRE) -- In a newly published edition of Special Topix™: Ophthalmology Pipeline Opportunities 2025 (US), research from Spherix Global Insights with U.S....
June 17, 2025 15:01 ET | Source: Spherix Global Insights

Pulmonologists and Rheumatologists Struggle to Diagnose and Manage CTD-ILD, According to New Research from Spherix Global Insights

EXTON, PA, June 17, 2025 (GLOBE NEWSWIRE) -- According to Spherix Global Insights’ newly published Special Topix™: Interstitial Lung Disease in Rheumatology (US) report, both rheumatologists and...
March 13, 2025 09:00 ET | Source: Salipro Biotech AB

Salipro Biotech et Boehringer Ingelheim concluent un accord de recherche et de licence en vue d’accélérer plusieurs programmes du pipeline de Boehringer Ingelheim

STOCKHOLM, 13 mars 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, société suédoise de biotechnologie spécialisée dans la stabilisation de cibles pharmacologiques difficiles à étudier, a annoncé ce...
March 13, 2025 09:00 ET | Source: Salipro Biotech AB

Salipro Biotech und Boehringer Ingelheim schließen Forschungs- und Lizenzvertrag zur Beschleunigung mehrerer Pipeline-Programme von Boehringer Ingelheim

STOCKHOLM, March 13, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, ein schwedisches Biotechnologieunternehmen, das sich auf die Stabilisierung anspruchsvoller Wirkstoffziele spezialisiert hat, gab...
March 13, 2025 09:00 ET | Source: Salipro Biotech AB

Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs

Salipro Biotech and Boehringer Ingelheim enter research and license agreement to accelerate multiple Boehringer Ingelheim pipeline programs.
January 15, 2024 07:30 ET | Source: DataHorizzon Research

Active Pharmaceutical Ingredients Market To Reach USD 346.4 Billion By 2032 at CAGR 8.7%| DataHorizzon Research

Colorado, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The Active Pharmaceutical Ingredients (API) Market size was valued at USD 151.2 Billion in 2022 and is expected to reach USD 346.4 Billion by 2032 at a...
October 30, 2023 03:20 ET | Source: Burning Rock Biotech Limited

Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics

Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
September 14, 2023 11:37 ET | Source: Spherix Global Insights

Amgen’s Amjevita Remains the Frontrunner in the US Adalimumab Biosimilars Market, Despite Increased Competition, According to Spherix Global Insights.

Exton, Pennsylvania, Sept. 14, 2023 (GLOBE NEWSWIRE) -- This summer ushered in the highly anticipated introduction of a multitude of additional adalimumab biosimilars to the dynamic US immunology...
June 28, 2023 08:30 ET | Source: Minerva Neurosciences, Inc

Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market

BURLINGTON, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...